|
1
|
Liu C, Lin J, Li L, Zhang Y, Chen W, Cao
Z, Zuo H, Chen C and Kee K: HPV16 early gene E5 specifically
reduces miRNA-196a in cervical cancer cells. Sci Rep. 5:76532015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zur Hausen H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Das BC, Hussain S, Nasare V and Bharadwaj
M: Prospects and prejudices of human papillomavirus vaccines in
India. Vaccine. 26:2669–2679. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heizmann CW, Fritz G and Schafer BW: S100
proteins: Structure, functions and pathology. Front Biosci.
7:1356–1368. 2002. View
Article : Google Scholar
|
|
5
|
An G, Xu Y, Shi L, Shizhen Z, Deng S, Xie
Z, Sui W, Zhan F and Qiu L: Chromosome 1q21 gains confer inferior
outcomes in multiple myeloma treated with bortezomib but copy
number variation and percentage of plasma cells involved have no
additional prognostic value. Haematologica. 99:353–359. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ha K, Shen Y, Graves T, Kim CH and Kim HG:
The presence of two rare genomic syndromes, 1q21 deletion and Xq28
duplication, segregating independently in a family with
intellectual disability. Mol Cytogenet. 9:742016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Duan L, Wu R, Zou Z, Wang H, Ye L, Li H,
Yuan S, Li X, Zha H, Sun H, et al: S100A6 stimulates proliferation
and migration of colorectal carcinoma cells through activation of
the MAPK pathways. Int J Oncol. 44:781–790. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Z, Tang M, Ling B, Liu S, Zheng Y, Nie
C, Yuan Z, Zhou L, Guo G, Tong A and Wei Y: Increased expression of
S100A6 promotes cell proliferation and migration in human
hepatocellular carcinoma. J Mol Med (Berl). 92:291–303. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Y, Wagner ER, Yan Z, Wang Z, Luther G,
Jiang W, Ye J, Wei Q, Wang J, Zhao L, et al: The Calcium-Binding
Protein S100A6 accelerates human osteosarcoma growth by promoting
cell proliferation and inhibiting osteogenic differentiation. Cell
Physiol Biochem. 37:2375–2392. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen X, Liu X, Lang H, Zhang S, Luo Y and
Zhang J: S100 calcium-binding protein A6 promotes
epithelial-mesenchymal transition through β-catenin in pancreatic
cancer cell line. PloS One. 10:e01213192015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang XH, Zhang LH, Zhong XY, Xing XF, Liu
YQ, Niu ZJ, Peng Y, Du H, Zhang GG, Hu Y, et al: S100A6
overexpression is associated with poor prognosis and is
epigenetically up-regulated in gastric cancer. Am J Pathol.
177:586–597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kilańczyk E, Graczyk A, Ostrowska H,
Kasacka I, Leśniak W and Filipek A: S100A6 is transcriptionally
regulated by β-catenin and interacts with a novel target, lamin
A/C, in colorectal cancer cells. Cell Calcium. 51:470–477. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li A, Shi D, Xu B, Wang J, Tang YL, Xiao
W, Shen G, Deng W and Zhao C: S100A6 promotes cell proliferation in
human nasopharyngeal carcinoma via the p38/MAPK signaling pathway.
Mol Carcinog. 56:972–984. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Joo JH, Kim JW, Lee Y, Yoon SY, Kim JH,
Paik SG and Choe IS: Involvement of NF-kappaB in the regulation of
S100A6 gene expression in human hepatoblastoma cell line HepG2.
Biochem Biophys Res Commun. 307:274–280. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Robbins HL and Hague A: The PI3K/Akt
pathway in tumors of endocrine tissues. Front Endocrinol
(Lausanne). 6:1882016.PubMed/NCBI
|
|
16
|
Saji M, Vasko V, Kada F, Allbritton EH,
Burman KD and Ringel MD: Akt1 contains a functional leucine-rich
nuclear export sequence. Biochem Biophys Res Commun. 332:167–173.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hers I, Vincent EE and Tavaré JM: Akt
signalling in health and disease. Cell Signal. 23:1515–1527. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Martelli AM, Tabellini G, Bressanin D,
Ognibene A, Goto K, Cocco L and Evangelisti C: The emerging
multiple roles of nuclear Akt. Biochim Biophys Acta.
1823:2168–2178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ocana A, Vera-Badillo F, Al-Mubarak M,
Templeton AJ, Corrales-Sanchez V, Diez-Gonzalez L, Cuenca-Lopez MD,
Seruga B, Pandiella A and Amir E: Activation of the PI3K/mTOR/AKT
pathway and survival in solid tumors: Systematic review and
meta-analysis. PloS One. 9:e952192014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Santamaria PG, Moreno-Bueno G, Portillo F
and Cano A: EMT: Present and future in clinical oncology. Mol
Oncol. 11:718–738. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miao JK, Lai TX, Zuo GW, et al: Expression
and purification of human S100A6-GST fusion protein. J Chongqing
Med Univ. 32:1009–1012. 2007.
|
|
22
|
Duan L, Wu R, Ye L, Wang H, Yang X, Zhang
Y, Chen X, Zuo G, Zhang Y, Weng Y, et al: S100A8 and S100A9 are
associated with colorectal carcinoma progression and contribute to
colorectal carcinoma cell survival and migration via Wnt/b-catenin
pathway. PloS One. 8:e620922013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song Q, Zhong L, Chen C, Tang Z, Liu H,
Zhou Y, Tang M, Zhou L, Zuo G, Luo J, et al: miR-21 synergizes with
BMP9 in osteogenic differentiation by activating the BMP9/Smad
signaling pathway in murine multilineage cells. Int J Mol Med.
36:1497–1506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nedjadi T, Kitteringham N, Campbell F,
Jenkins RE, Park BK, Navarro P, Ashcroft F, Tepikin A, Neoptolemos
JP and Costello E: S100A6 binds to annexin 2 in pancreatic cancer
cells and promotes pancreatic cancer cell motility. Br J Cancer.
101:1145–1154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yuan T: The expression of tumour
metastasis-associated genes S100A6, Rab5a in cervical cancer and
its clinical significance. Guangxi Medical University. 2010.
|
|
26
|
Kuźnicki J, Kordowska J, Puzianowska M and
Woźniewicz BM: Calcyclin as a marker of human epithelial cells and
fibroblasts. Exp Cell Res. 200:425–430. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lesniak W, Slomnicki LP and Filipek A:
S100A6-new facts and features. Biochem Biophys Res Commun.
390:1087–1092. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiao M, Xu Q, Li H, Gao H, Bie Y and Zhang
Z: Prevalence of human papillomavirus genotypes among women with
high-grade cervical lesions in Beijing, China. Medicine
(Baltimore). 95:e25552016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schwartz SM, Daling JR, Shera KA,
Madeleine MM, McKnight B, Galloway DA, Porter PL and McDougall JK:
Human papillomavirus and prognosis of invasive cervical cancer: A
population-based study. J Clin Oncol. 19:1906–1915. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bansal A, Singh MP and Rai B: Human
papillomavirus-associated cancers: A growing global problem. Int J
Appl Basic Med Res. 6:84–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hua Z, Chen J, Sun B, Zhao G, Zhang Y,
Fong Y, Jia Z and Yao L: Specific expression of osteopontin and
S100A6 in hepatocellular carcinoma. Surgery. 149:783–791. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bedi U, Mishra VK, Wasilewski D, Scheel C
and Johnsen SA: Epigenetic plasticity: A central regulator of
epithelial-to-mesenchymal transition in cancer. Oncotarget.
5:2016–2029. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Baum B, Settleman J and Quinlan MP:
Transitions between epithelial and mesenchymal states in
development and disease. Semin Cell Dev Biol. 19:294–308. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li L and Li W: Epithelial-mesenchymal
transition in human cancer: Comprehensive reprogramming of
metabolism, epigenetics, and differentiation. Pharmacol Ther.
150:33–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang WN, Li W, Wang XL, Hu Z, Zhu D, Ding
WC, Liu D, Li KZ, Ma D and Wang H: CLDN1 expression in cervical
cancer cells is related to tumor invasion and metastasis.
Oncotarget. 7:87449–87461. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kucia-Tran JA, Tulkki V, Smith S, Scarpini
CG, Hughes K, Araujo AM, Yan KY, Botthof J, Pérez-Gómez E,
Quintanilla M, et al: Overexpression of the oncostatin-M receptor
in cervical squamous cell carcinoma is associated with
epithelial-mesenchymal transition and poor overall survival. Br J
Cancer. 115:212–222. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu Y, Wang Y, Chen C, Zhang J, Qian W,
Dong Y, Liu Z, Zhang X, Wang X, Zhang Z, et al: LSD1 binds to HPV16
E7 and promotes the epithelial-mesenchymal transition in cervical
cancer by demethylating histones at the Vimentin promoter.
Oncotarget. 8:11329–11342. 2016.
|
|
39
|
Chen Q, Cao HZ and Zheng PS: LGR5 promotes
the proliferation and tumor formation of cervical cancer cells
through the Wnt/β-catenin signaling pathway. Oncotarget.
5:9092–9105. 2014.PubMed/NCBI
|
|
40
|
Kong L, Hao Q, Wang Y, Zhou P, Zou B and
Zhang YX: Regulation of p53 expression and apoptosis by vault
RNA2-1-5p in cervical cancer cells. Oncotarget. 6:28371–28388.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rashmi R, DeSelm C, Helms C, Bowcock A,
Rogers BE, Rader JL, Grigsby PW and Schwarz JK: AKT inhibitors
promote cell death in cervical cancer through disruption of mTOR
signaling and glucose uptake. PloS One. 9:e929482014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu T, Liu Y, Bao X, Tian J, Liu Y and
Yang X: Overexpression of TROP2 predicts poor prognosis of patients
with cervical cancer and promotes the proliferation and invasion of
cervical cancer cells by regulating ERK signaling pathway. PloS
One. 8:e758642013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang SX, Polley E and Lipkowitz S: New
insights on PI3K/AKT pathway alterations and clinical outcomes in
breast cancer. Cancer Treat Rev. 45:87–96. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Feng T, Zheng L, Liu F, Xu X, Mao S, Wang
X, Liu J, Lu Y, Zhao W, Yu X and Tang W: Growth factor progranulin
promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR
signaling pathway. Oncotarget. 7:58381–58395. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qian S and Li M: Chamaejasmine induces
apoptosis in HeLa cells through the PI3K/Akt signaling pathway.
Anticancer Drugs. 28:40–50. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jeyamohan S, Moorthy RK, Kannan MK and
Arockiam AJ: Parthenolide induces apoptosis and autophagy through
the suppression of PI3K/Akt signaling pathway in cervical cancer.
Biotechnol Lett. 38:1251–1260. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hagemann T, Bozanovic T, Hooper S, Ljubic
A, Slettenaar VI, Wilson JL, Singh N, Gayther SA, Shepherd JH and
Van Trappen PO: Molecular profiling of cervical cancer progression.
Br J Cancer. 96:321–328. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ke LR, Xiang YQ, Guo X, Lu J, Xia W, Yu Y,
Peng Y, Wang L, Wang G, Ye Y, et al: c-Src activation promotes
nasopharyngeal carcinoma metastasis by inducing the
epithelial-mesenchymal transition via PI3K/Akt signaling pathway: A
new and promising target for NPC. Oncotarget. 7:28340–28355. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang H, Zou Z, Duan L, Chen X, Li H, Yuan
S, He TC and Zhou L: S100A6 promotes proliferation and migration of
human osteosarcoma cell line 143B through PI3K/Akt signaling
pathway. Chin J Pathophysiol. 29:1928–1933. 2013.
|
|
50
|
Hui S: Exogenous S100A6 upregulates its
own expression in colorectal carcinoma cells and its mechanism.
Chongqing Medical University. 2013.
|
|
51
|
Sparvero LJ, Asafu-Adjei D, Kang R, Tang
D, Amin N, Im J, Rutledge R, Lin B, Amoscato AA, Zeh HJ and Lotze
MT: RAGE (Receptor for Advanced Glycation Endproducts), RAGE
ligands, and their role in cancer and inflammation. J Transl Med.
7:172009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chen H, Xu C, Jin Q and Liu Z: S100
protein family in human cancer. Am J Cancer Res. 4:89–115.
2014.PubMed/NCBI
|
|
53
|
Bresnick AR, Weber DJ and Zimmer DB: S100
proteins in cancer. Nat Rev Cancer. 15:96–109. 2015. View Article : Google Scholar : PubMed/NCBI
|
